Aisyah Noor
Stock Analyst at Morgan Stanley
(2.81)
# 2,856
Out of 4,703 analysts
143
Total ratings
51.5%
Success rate
3.3%
Average return
Main Sectors:
Stocks Rated by Aisyah Noor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: CTEC Convatec Group PLC | Maintained: Buy | 270p → 289p | 228p | +26.64% | 5 | Sep 2, 2026 | |
| LON: SN Smith & Nephew plc | Downgraded: Hold | 1,304p → 1,158p | 1,064p | +8.83% | 7 | Sep 2, 2026 | |
| SWX: TECN Tecan Group AG | Maintained: Hold | CHF 142.00 → CHF 160.00 | CHF 194.90 | -17.91% | 17 | Aug 13, 2026 | |
| WILLF Demant A/S | Maintained: Buy | $45 → $46 | $44.03 | +4.45% | 9 | Aug 13, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €49.00 → €52.00 | €43.63 | +19.18% | 6 | Aug 10, 2026 | |
| QGEN Qiagen | Maintained: Buy | $42 → $46 | $43.47 | +6.92% | 23 | Aug 7, 2026 | |
| ETR: FME Fresenius Medical Care AG | Maintained: Sell | €32.00 → €31.00 | €39.22 | -20.96% | 7 | Aug 5, 2026 | |
| SWX: STMN Straumann Holding AG | Maintained: Sell | CHF 81.00 → CHF 85.00 | CHF 93.94 | -9.52% | 5 | Jun 30, 2026 | |
| EPA: BIM bioMérieux S.A. | Downgraded: Sell | €100.00 → €64.00 | €74.25 | -13.80% | 9 | Jun 23, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Maintained: Hold | €26.00 → €25.00 | €22.35 | +11.86% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | CHF 172.00 → CHF 205.00 | CHF 234.80 | -12.69% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €41.00 → €37.00 | €39.00 | -5.13% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €65.00 → €60.00 | €75.36 | -20.38% | 16 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | kr 535.00 → kr 541.00 | kr 463.00 | +16.85% | 9 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 159.00 → CHF 161.00 | CHF 126.00 | +27.78% | 7 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 182.00 → kr 175.00 | kr 241.80 | n/a | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 22.00 → CHF 20.00 | CHF 10.79 | n/a | 8 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €140.00 → €147.00 | €59.55 | n/a | 2 | Mar 12, 2025 |
Convatec Group PLC
Sep 2, 2026
Maintained: Buy
Price Target: 270p → 289p
Current: 228p
Upside: +26.64%
Smith & Nephew plc
Sep 2, 2026
Downgraded: Hold
Price Target: 1,304p → 1,158p
Current: 1,064p
Upside: +8.83%
Tecan Group AG
Aug 13, 2026
Maintained: Hold
Price Target: CHF 142.00 → CHF 160.00
Current: CHF 194.90
Upside: -17.91%
Demant A/S
Aug 13, 2026
Maintained: Buy
Price Target: $45 → $46
Current: $44.03
Upside: +4.45%
Fresenius SE & Co. KGaA
Aug 10, 2026
Maintained: Buy
Price Target: €49.00 → €52.00
Current: €43.63
Upside: +19.18%
Qiagen
Aug 7, 2026
Maintained: Buy
Price Target: $42 → $46
Current: $43.47
Upside: +6.92%
Fresenius Medical Care AG
Aug 5, 2026
Maintained: Sell
Price Target: €32.00 → €31.00
Current: €39.22
Upside: -20.96%
Straumann Holding AG
Jun 30, 2026
Maintained: Sell
Price Target: CHF 81.00 → CHF 85.00
Current: CHF 93.94
Upside: -9.52%
bioMérieux S.A.
Jun 23, 2026
Downgraded: Sell
Price Target: €100.00 → €64.00
Current: €74.25
Upside: -13.80%
Koninklijke Philips N.V.
Jun 23, 2026
Maintained: Hold
Price Target: €26.00 → €25.00
Current: €22.35
Upside: +11.86%
Jun 23, 2026
Upgraded: Hold
Price Target: CHF 172.00 → CHF 205.00
Current: CHF 234.80
Upside: -12.69%
Jun 23, 2026
Maintained: Hold
Price Target: €41.00 → €37.00
Current: €39.00
Upside: -5.13%
Mar 23, 2026
Maintained: Hold
Price Target: €65.00 → €60.00
Current: €75.36
Upside: -20.38%
Dec 15, 2025
Maintained: Sell
Price Target: kr 535.00 → kr 541.00
Current: kr 463.00
Upside: +16.85%
Sep 9, 2025
Maintained: Buy
Price Target: CHF 159.00 → CHF 161.00
Current: CHF 126.00
Upside: +27.78%
Jul 23, 2025
Maintained: Hold
Price Target: kr 182.00 → kr 175.00
Current: kr 241.80
Upside: n/a
Mar 18, 2025
Maintained: Hold
Price Target: CHF 22.00 → CHF 20.00
Current: CHF 10.79
Upside: n/a
Mar 12, 2025
Maintained: Hold
Price Target: €140.00 → €147.00
Current: €59.55
Upside: n/a